Rovida et al., 2015 - Google Patents
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinomaRovida et al., 2015
View PDF- Document ID
- 11392387194559176933
- Author
- Rovida E
- Di Maira G
- Tusa I
- Cannito S
- Paternostro C
- Navari N
- Vivoli E
- Deng X
- Gray N
- Esparís-Ogando A
- David E
- Pandiella A
- Sbarba P
- Parola M
- Marra F
- Publication year
- Publication venue
- Gut
External Links
Snippet
Objective The extracellular signal-regulated kinase 5 (ERK5 or BMK1) is involved in tumour development. The ERK5 gene may be amplified in hepatocellular carcinoma (HCC), but its biological role has not been clarified. In this study, we explored the role of ERK5 expression …
- 102100005530 MAPK7 0 title abstract description 183
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rovida et al. | The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma | |
| Zhong et al. | YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma | |
| Bayraktar et al. | Dual suppressive effect of miR-34a on the FOXM1/eEF2-kinase axis regulates triple-negative breast cancer growth and invasion | |
| Zhou et al. | MicroRNA-195 suppresses the progression of pancreatic cancer by targeting DCLK1 | |
| Ghosh et al. | MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2 | |
| Zhao et al. | Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial‐mesenchymal transition regulator Twist1 | |
| Adams et al. | The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas | |
| Yu et al. | MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells | |
| Liang et al. | Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122 | |
| Chaturvedi et al. | Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis | |
| Cheng et al. | AS1411-induced growth inhibition of glioma cells by up-regulation of p53 and down-regulation of Bcl-2 and Akt1 via nucleolin | |
| Ma et al. | MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2 | |
| Liu et al. | miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1 | |
| Wang et al. | FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition | |
| Fan et al. | miR‐122 promotes metastasis of clear‐cell renal cell carcinoma by downregulating Dicer | |
| Zhang et al. | A SOX9‐AS1/miR‐5590‐3p/SOX9 positive feedback loop drives tumor growth and metastasis in hepatocellular carcinoma through the Wnt/β‐catenin pathway | |
| Shen et al. | miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT | |
| Hong et al. | Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition | |
| Chen et al. | Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter | |
| Zhang et al. | SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma | |
| Wang et al. | LINC00511 promotes proliferation and invasion by sponging miR-515-5p in gastric cancer | |
| Liu et al. | Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway | |
| Chen et al. | miR-331-3p functions as an oncogene by targeting ST7L in pancreatic cancer | |
| Zhao et al. | miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2 | |
| Cai et al. | MiR-124 inhibits the migration and invasion of human hepatocellular carcinoma cells by suppressing integrin αV expression |